Optimization of antirheumatic leflunomide therapy by therapeutic drug monitoring

被引：0
|
作者：
van Roon, EN
Botta-Steeneken, NA
Jansen, TLTA
Wilffert, B
Brouwers, JRBJ
机构：
[1] Med Ctr Leeuwarden, Dept Clin Pharm & Pharmacol, NL-8901 BR Leeuwarden, Netherlands
[2] Med Ctr Leeuwarden, Dept Rheumatol, NL-8901 BR Leeuwarden, Netherlands
[3] Univ Groningen, GUIDE, Subdiv Social Pharm Pharmacoepidemiol & Pharmacot, NL-9713 AW Groningen, Netherlands
[4] Univ Bonn, Dept Pharmacol & Toxicol, D-53121 Bonn, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
622
引用
收藏
页码：R156 / R156
页数：1
相关论文
共 50 条
  • [1] Optimization of Antimicrobial Therapy Based on Therapeutic Drug Monitoring
    Morita, Kunihiko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (10): : 1407 - 1413
  • [2] THERAPEUTIC EFFECTS OF LEFLUNOMIDE, A NEW ANTIRHEUMATIC DRUG, ON GLOMERULONEPHRITIS INDUCED BY THE ANTIBASEMENT MEMBRANE ANTIBODY IN RATS
    OGAWA, T
    INAZU, M
    GOTOH, K
    INOUE, T
    HAYASHI, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 61 (01): : 103 - 118
  • [3] Pilot study of therapeutic drug monitoring of leflunomide in renal transplant
    Barau, C.
    Lahlou, A.
    Bazin, C.
    Grimbert, P.
    Francois, H.
    Blanchet, B.
    Astier, A.
    Furlan, V.
    Hulin, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 89 - 89
  • [4] Leflunomide:: new antirheumatic drug -: Effect on pregnancy outcomes
    Kozer, E
    Moretti, ME
    Koren, G
    CANADIAN FAMILY PHYSICIAN, 2001, 47 : 721 - 722
  • [5] Therapeutic drug monitoring and objective symptom rating for optimization of antipsychotic drug therapy
    Nazirizadeh, Y.
    Hiemke, C.
    Vogel, F.
    Dragicevic, A.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 227 - 227
  • [6] The efficacy of leflunomide monotherapy in rheumatoid arthritis: Towards the goals of disease modifying antirheumatic drug therapy
    Smolen, JS
    Emery, P
    Kalden, JR
    Van Riel, PLCM
    Dougados, M
    Strand, CV
    Breedveld, FC
    JOURNAL OF RHEUMATOLOGY, 2004, 31 : 13 - 20
  • [7] Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing
    Cattaneo, D
    Merlini, S
    Pellegrino, M
    Carrara, F
    Zenoni, S
    Murgia, S
    Baldelli, S
    Gaspari, F
    Remuzzi, G
    Perico, N
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (08) : 1345 - 1351
  • [8] An update on therapeutic drug monitoring and pharmacogenetic testing for the optimization of therapy with psychiatric medication
    Rentsch, Katharina M.
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2014, 38 (02): : 63 - 74
  • [9] Therapeutic drug monitoring of antiretroviral therapy
    Rakhmanina, NY
    Van den Anker, JN
    Soldin, SJ
    AIDS PATIENT CARE AND STDS, 2004, 18 (01) : 7 - 14
  • [10] Therapeutic Drug Monitoring of Leflunomide (A77 1726) as an Immunosuppressive (IS) Alternative in Thoracic Transplantation
    Lefeuvre, S.
    Faiz, I
    Guillemain, R.
    Chevalier, P.
    Boussaud, V
    Amrein, C.
    Le Beller, C.
    Billaud, E. M.
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 625 - 625
12345